Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive StudyOriginal Paper Published on 2021-09-272022-10-29 Journal: Jmirx Med [Category] COVID-19, [키워드] 95% CI Admission Analysis antibody approach benefit Care Charlson Comorbidity Index Comorbidities Control control group covariate COVID-19 COVID-19 test Cox model demographics drug Efficacy eligible Establishing experience hazard ratio Health high risk Hospitalization Hospitalized immune therapy Immunotherapy In-hospital in-hospital mortality Infectious disease Mild Model Moderate COVID-19 monoclonal antibody monoclonal antibody therapy Mortality multivariable Neutralizing New York objective outcome pandemic Patient patient outcome positive COVID-19 presenting Primary outcome Probability receive reduce released Result retrospective cohort risk severe COVID-19 Sociodemographic study period survival symptom onset therapy to define Treatment vital signs was used Weighting [DOI] 10.2196/29638 PMC 바로가기 [Article Type] Original Paper
The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 PandemicReview Published on 2021-09-162022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] activities association associations Care China Community competent Complete Complication conducted coronavirus 2 counseling country COVID-19 COVID-19 pandemic COVID-19 pathology COVID-19 patients COVID-19 test deaths disease drug extension facilitate global healthcare Health health system healthcare healthcare services hospital identify implementation Improving information management measure pandemic pathology Patient Patient care performed pharmaceutical Pharmaceutical care pharmaceutical practice pharmaceutical services Pharmacist Pharmacy produced professionals provided Public public health quarantine Regulation respiratory SARS-CoV-2 service Support Treatment Vaccines [DOI] 10.3390/ijerph18189776 PMC 바로가기 [Article Type] Review
A Bayesian method for synthesizing multiple diagnostic outcomes of COVID-19 testsMathematics Published on 2021-09-152022-10-28 Journal: Royal Society Open Science [Category] COVID-19, [키워드] Accuracy assertion assist Bayesian Bayesian posterior build calculated Chest computed tomography clinical evaluation consequence COVID-19 COVID-19 test COVID-19 tests demonstrated detect Diagnostic method diagnostic outcome diagnostic test false-negative infections multiple testing multiple tests integration novel coronavirus disease online tool outcome pandemic patient treatment physician posterior probability Precision Probability reverse transcription–polymerase chain reaction SARS-CoV-2 SARS-COV-2 infection Sensitivity and specificity Serological tests Spread subject [DOI] 10.1098/rsos.201867 PMC 바로가기 [Article Type] Mathematics
New-Onset Psychosis Following COVID-19 InfectionPsychiatry Published on 2021-09-122022-10-31 Journal: Cureus [Category] COVID-19, [키워드] amplify Care consequence contributed coronavirus disease COVID 19 COVID-19 COVID-19 infection COVID-19 test dexamethasone 6 mg disorder Effect ENhance etiology exhibiting female had no haloperidol hospital Hospital stay identify increased risk individual Infection likelihood medication Neuropsychiatric neuropsychiatric manifestations Novel coronavirus oxygen Patient presenting previous study problem Prognosis psychiatric history Psychiatric symptoms psychiatry Psychosis psychosocial stressors Remdesivir Research risk risk factor Seven sodium Steroids Symptom Symptoms symptoms of COVID-19 systemic steroids the patient therapy treated variable while [DOI] 10.7759/cureus.17904 PMC 바로가기 [Article Type] Psychiatry
In-house reverse transcriptase polymerase chain reaction for detection of SARS-CoV-2 with increased sensitivity증가 된 감도와 SARS-COV-2의 검출을위한 사내 역전사 효소 중합 효소 연쇄 반응Article Published on 2021-09-092022-09-01 Journal: Scientific Reports [Category] SARS, 변종, 진단, 치료기술, 치료제, [키워드] added advent amplification amplify amplifying applicability approach concentrations Concordance COVID-19 disease COVID-19 infection COVID-19 test demonstrated Dilution Epidemiology help management multiplex Multiplex PCR Multiplexing offer pandemic PCR condition polymerase chain positive sample primer Primers RdRP real time Real-time PCR relief resource RT-PCR SARS-CoV-2 SARS-CoV-2 genes sensitivity sets of primers shown significantly SYBR Green the SARS-CoV-2 transcriptase variable [DOI] 10.1038/s41598-021-97502-1 PMC 바로가기 [Article Type] Article
Emotional Control among Nurses against Work Conditions and the Support Received during the SARS-CoV-2 PandemicArticle Published on 2021-09-062022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] anger caused condition conditions Control COVID-19 COVID-19 test Depression emotional emotional control evaluate fear highest hospitals material Mental non-infectious Nurse Nurses occurred pandemic questionnaire Received repressed Research scale significantly Stress stress levels Support the SARS-CoV-2 the SARS-CoV-2 virus was performed were used work working [DOI] 10.3390/ijerph18179415 PMC 바로가기 [Article Type] Article
Aspirin Is Related to Worse Clinical Outcomes of COVID-19Observational Study Published on 2021-09-042022-10-04 Journal: Medicina [Category] SARS, 임상, [키워드] adverse effect applied Aspirin association baseline characteristics clinical coronavirus disease COVID-19 COVID-19 patients COVID-19 test COVID-19 testing death death rate Diagnosis eligible eligible patient evaluated higher risk insurance intensive care investigated Korean material mechanical ventilation mechanism not significantly different objective Observational cohort study outcome Oxygen therapy Pain Patient Primary outcome propensity score matching reduce retrospective secondary outcome South Korea System was related [DOI] 10.3390/medicina57090931 PMC 바로가기 [Article Type] Observational Study
Assessing the capacity of symptom scores to predict COVID-19 positivity in Nigeria: a national derivation and validation cohort studyEpidemiology Published on 2021-09-032022-10-28 Journal: BMJ Open [Category] COVID-19, Fulltext, SARS, [키워드] 95% CI approach Assessing AUROC Capital characteristic children coefficient Cohort cough COVID-19 COVID-19 test dataset datasets develop difficulty in breathing elderly patients Epidemiology Fever identify individual individual symptoms Loss of Smell measure molecular multivariable logistic regression National Nigeria objective participant Patient patients positive predict Predictive public health Randomly Real-time PCR resource Result setting state statistical Surveillance Symptom territory tested validation cohort was used were used with COVID-19 [DOI] 10.1136/bmjopen-2021-049699 PMC 바로가기 [Article Type] Epidemiology
Rasch Model of the COVID-19 Symptom Checklist—A Psychometric Validation StudyArticle Published on 2021-09-032022-10-28 Journal: Viruses [Category] COVID-19, SARS, [키워드] Adjustment age Analysis Combination Comorbidities Comorbidity construct validity coronavirus COVID-19 COVID-19 symptom COVID-19 test educational status examined Factor Factors Gender highest Immunosuppressive medication increase internal consistency Interpretation likelihood lockdown Model pandemic Perspective pollen allergy Pregnancy ranged SARS CoV-2 self-reported instrument specific symptom sputum suggested Support Symptom symptom checklist validation while [DOI] 10.3390/v13091762 PMC 바로가기 [Article Type] Article
Predictors of COVID-19 epidemics in countries of the World Health Organization African Region세계보건기구(WHO) 아프리카 지역 국가의 COVID-19 전염병 예측자Article Published on 2021-09-032022-09-10 Journal: Nature Medicine [Category] MERS, SARS, 치료기술, [키워드] affected African association benefit coronavirus disease Coronavirus disease 2019 country COVID-19 COVID-19 case COVID-19 pandemic COVID-19 test detect Epidemics Epidemiology feature First wave Government greater Health Organization Health policy health system health systems highlight HIV identify Infectious disease International Mortality mortality rate observational study pandemic populations predict predicted predictor Prevalence Region responses Risk factors second second wave the disease the timing the WHO urban population urban populations WHO World Health Organization [DOI] 10.1038/s41591-021-01491-7 PMC 바로가기 [Article Type] Article